|
ABCD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.136400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.060100E-03 |
| Normal-vs-Stage2 |
7.355400E-01 |
| Normal-vs-Stage3 |
7.030400E-01 |
| Normal-vs-Stage4 |
1.523400E-01 |
| Stage1-vs-Stage2 |
1.143780E-01 |
| Stage1-vs-Stage3 |
8.981000E-04 |
| Stage1-vs-Stage4 |
7.52050000000226E-05 |
| Stage2-vs-Stage3 |
5.771800E-01 |
| Stage2-vs-Stage4 |
2.120600E-01 |
| Stage3-vs-Stage4 |
3.079600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.409400E-01 |
| Normal-vs-AfricanAmerican |
3.397900E-02 |
| Normal-vs-Asian |
8.507600E-02 |
| Caucasian-vs-AfricanAmerican |
7.007700E-02 |
| Caucasian-vs-Asian |
3.371700E-02 |
| AfricanAmerican-vs-Asian |
4.896000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.967400E-01 |
| Normal-vs-Female |
1.027320E-04 |
| Male-vs-Female |
3.17169999997091E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.863400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.860060E-02 |
| Normal-vs-Age(61-80Yrs) |
5.968200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.539800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.747020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.113800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.235000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.249700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.024000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.861000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.124200E-03 |
| Normal-vs-Grade 2 |
8.418600E-04 |
| Normal-vs-Grade 3 |
8.417800E-01 |
| Normal-vs-Grade 4 |
1.829910E-04 |
| Grade 1-vs-Grade 2 |
1.325850E-02 |
| Grade 1-vs-Grade 3 |
4.399400E-03 |
| Grade 1-vs-Grade 4 |
1.020080E-03 |
| Grade 2-vs-Grade 3 |
1.404020E-03 |
| Grade 2-vs-Grade 4 |
6.53199716538211E-11 |
| Grade 3-vs-Grade 4 |
7.71480000000269E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.82460000003526E-06 |
| Normal-vs-ccB subtype |
5.498900E-03 |
| ccA subtype-vs-ccB subtype |
1.64357416565508E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.693600E-02 |
| Normal-vs-N1 |
3.397900E-04 |
| N0-vs-N1 |
1.008520E-04 |
|
|
